Induction of growth inhibition of 293 cells by downregulation of the cyclin E and cyclin-dependent kinase 4 proteins due to overexpression of TIS21

Molecular Carcinogenesis

Volumn 23, Issue 1, 1998, Pages 25-35

  Lim, In Kyoung ^a   Lee, Myung Soog ^a   Ryu, Min Sook ^a   Park, Tae Jun ^a   Fujiki, Hirota ^b   Eguchi, Hidetaka ^b   Paik, Woon Ki ^a  

^a Ajou University School of Medicine   (South Korea)

^b SAITAMA CANCER CENTER   (Japan)

Author keywords

Cyclin E associated cdk activity; G1 arrest; TIS21

Indexed keywords

CANCER GROWTH FACTOR; CYCLIN DEPENDENT KINASE; CYCLIN E; FORSKOLIN; GROWTH FACTOR; HISTONE H1; REGULATOR PROTEIN; THYMIDINE; UBIQUITIN;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; DNA SYNTHESIS; DNA TRANSFECTION; FIBROBLAST; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RESTRICTION SITE; SEQUENCE HOMOLOGY; TISSUE DISTRIBUTION; TRANSLATION REGULATION;

ANIMALS; BASE SEQUENCE; CELL CYCLE PROTEINS; CELL DIVISION; CELL LINE; CLONING, MOLECULAR; CYCLIN E; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; DNA PRIMERS; DOWN-REGULATION; GENES, TUMOR SUPPRESSOR; HUMANS; IMMEDIATE-EARLY PROTEINS; MICE; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

MUS MUSCULUS; SIMIAE; SIMIAN VIRUS; SIMIAN VIRUS 40;

EID: 0009743759     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199809)23:1<25::AID-MC4>3.0.CO;2-G     Document Type: Article

References (56)

1. Herschman HR. Primary response genes induced by growth factors and tumor promoters. Ann Rev Biochem 60:281-319, 1991.
2. Lim RW, Varnum BC, Herschman HR. Cloning of tetradecanoylphorbol ester induced "primary response" sequences and their expression in density-arrested Swiss 3T3 cells and TPA nonproliferative variants. Oncogene 1:263-270, 1987.
3. Bradbury A, Possenti R, Shooter EM, Tirone F. Molecular cloning of PC3, a putative secreted protein whose mRNA is induced by nerve growth factor and depolarization. Proc Natl Acad Sci USA 88:3353-3357, 1991.
4. Rouault JP, Falette N, Guehenneux F, et al. Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway. Nat Genet 14:482-486, 1996.
5. Rimokh R, Rouault JP, Wahbi K, et al. A chromosome 12 coding region is juxtaposed to the MYC proto-oncogene locus in a t(8;12)(q24;q22) translocation in a case of B-cell chronic lymphocytic leukemia. Genes Chromosomes Cancer 3:24-36, 1991.
6. Rouault JP, Rimokh R, Tessa C, et al. BTG-1, a member of a new family of antiproliferative genes. EMBO J 11:1663-1670, 1992.
7. Montagnoli A, Guardavaccaro D, Starace G, Tirone F. Overexpression of the nerve growth factor-inducible PC3 immediate early gene is associated with growth inhibition. Cell Growth Differ 7:1327-1336, 1996.
8. erbB2, is associated with anti-proliferative activity. Oncogene 12:705-713, 1996.
9. Guehenneux F, Duret L, Callanan MB, et al. Cloning of the mouse BTG3 gene and definition of a new gene family (the BTG family) involved in the negative control of the cell cycle. Leukemia 11:370-375, 1997.
10. Varnum BC, Reddy ST, Koski RA, Herschman HR. Synthesis, degradation, and subcellular localization of proteins encoded by the primary response genes TIS7/PC4 and TIS21/PC3. J Cell Physiol 158:205-213, 1994.
11. Cmarik JL, Herschman H, Colburn NH. Preferential primary response gene expression in promotion-resistant vs. promotion-sensitive JB6 cells. Mol Carcinog 11:115-124, 1994.
12. Lim IK, Kim NK, Lee MS, et al. Differential expression of TIS21 and TIS1 genes in the various organs of BALB/c mice, thymic carcinoma tissues and human cancer cell lines. J Cancer Res Clin Oncol 121:279-284, 1995.
13. Graham FL, Smiley J, Russell WC, Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type S. J Gen Virol 36:59-74, 1977.
14. Fletcher BS, Lim RW, Varnum BC, Kujubu DA, Koski RA, Herschman HR. Structure and expression of TIS-21, a primary response gene induced by growth factors and tumor promoters. J Biol Chem 266:14511-14518, 1991.
15. Lim IK, Kim NK, Lee MS, Lee SH. Expression of TIS21 gene during the development of BALB/c mice and the liver regeneration. Korean Journal of Biochemistry 26:169-175, 1994.
16. Yasukawa T, Kanei-Ishii C, Maekawa T, Fujimoto J, Yamamoto T, Ishii S. Increase of solubility of foreign proteins in Escherichia coli by coproduction of the bacterial thioredoxin. J Biol Chem 270:25328-25331, 1995.
17. Lee MS, Hong L, Lim IK. Expression of TIS21 in the embryonic liver of BALB/c mouse. Ajou Medical Journal 1:99-104, 1996.
18. Pardee AB. G1 events and regulation of cell proliferation. Science 246:603-608, 1989.
19. Strauss B, Lukas J, Bartek J. Unrestricted cell cycling and cancer. Nat Med 1:1245-1246, 1995.
20. Xiong Y, Zhang H, Beach D. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71:505-514, 1992.
21. Won KA, Xiong Y, Beach D, Gilman MZ. Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts. Proc Natl Acad Sci USA 89:9910-9914, 1992.
22. Koff A, Cross F, Fisher A, et al. Human cyclin E, a new cyclin that interacts with two members of CDK2 gene family. Cell 66:1217-1228, 1991.
23. Dulic V, Lee E, Reed SI. Association of human cyclin E with a periodic G1-S phase protein kinase. Science 257:1958-1961, 1992.
24. Koff A, Giordano A, Desai D, et al. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science 257:1689-1694, 1992.
25. Reed SI, Wittenberg C, Lew DJ, Dulic V, Henze M. G1 control in yeast and animal cells. Cold Spring Harb Symp Quant Biol 56:61-67, 1991.
26. Ohtsubo M, Roberts JM. Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science 259:1908-1912, 1993.
27. Sherr CJ. Mammalian G1 cyclins. Cell 73:1059-1063, 1993.
28. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 81:323-330, 1995.
29. Nevins JR, Leone G, DeGregori J, Jakoi L. Role of the Rb/E2F pathway in cell growth control. J Cell Phys 173:233-236, 1997.
30. Leng X, Connell-Crowley L, Goodrich D, Harper JW. S-phase entry upon ectopic expression of G1 cyclin-dependent kinases in the absence of retinoblastoma protein phosphorylation. Curr Biol 7:709-712, 1997.
31. Duronio RJ, Bonnette PC, O'Farrell PH. Mutations of the Drosophila dDP, dE2F, and cyclin E genes reveal distinct roles for the E2F-DP transcription factor and cyclin E during the G1-S transition. Mol Cell Biol 18:141-151, 1998.
32. Gray-Bablin J, Zalvide J, Fox MP, Knickerbocker CJ, DeCaprio JA, Keyomarsi K. Cyclin E, a redundant cyclin in breast cancer. Proc Natl Acad Sci USA 93:15215-15220, 1996.
33. INK4 requires functional retinoblastoma protein. Proc Natl Acad Sci USA 92:6289-6293, 1995.
34. Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9:1149-1163, 1995.
35. Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM, Pagano M. Human cyclin E, a nuclear protein essential for the G1 to S phase transition. Mol Cell Biol 15:2612-2624, 1995.
36. Kamb A. Cell-cycle regulators and cancer. Trends Genet 11:136-140, 1995.
37. Grana X, Reddy EP. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CDKIs). Oncogene 11:211-219, 1995.
38. INK4 expression in primary lung cancers and cell lines. Cancer Res 55:505-509, 1995.
39. INK4 and retinoblastoma tumour-suppressor genes occur in a distinct subset of human cancer cell lines. Int J Cancer 61:115-120, 1995.
40. INK4 protein is restricted to the subset of lung cancer lines that retains wild type RB. Oncogene 9:3375-3378, 1994.
41. INK4/MTS1 tumor suppressor gene products. EMBO J 14: 503-511, 1995.
42. Medena RH, Herrera RE, Lam F, Weinberg RA. Growth suppression by p16ink4 requires functional retinoblastoma protein. Proc Natl Acad Sci USA 92:6289-6293, 1995.
43. Lukas J, Parry D, Aagaard L, et al. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature 375:503-506, 1995.
44. Grana X, Reddy EP. Cell cycle control in mammalian cells: Role of cyclins, cyclin dependent kinase (cdks), growth suppressor genes and cyclin dependent kinase inhibitors (CDKIs). Oncogene 11:211-219, 1995.
45. Moran E. Interaction of adenoviral proteins with pRB and p53. FASEB J 7:880-885, 1993.
46. Sgambato A, Han EK, Zhou P, Schieren I, Weinstein IB. Overexpression of cyclin E in the HC11 mouse mammary epithelial cell line is associated with growth inhibition and increased expression of p27(KIP1). Cancer Res 56:1389-1399, 1996.
47. Haas K, Johannes C, Geisen C, et al. Malignant transformation by cyclin E and Ha-ras correlates with lower sensitivity towards induction of cell death but requires functional Myc and cdk4. Oncogene 15:2615-2623, 1997.
48. Keyomarsi K, O'Leary N, Molnar G, Lees E, Fingert HJ, Pardee AB. Cyclin E, a potential prognostic marker for breast cancer. Cancer Res 54:380-385, 1994.
49. Keyomarsi K, Conte D Jr, Toyofuku W, Fox MP. Deregulation of cyclin E in breast cancer. Oncogene 11:941-950, 1995.
50. Jin YM, Yim H, Shim C. Cyclin E expression in benign and malignant epithelial neoplasms of the gallbladder. Yonsei Med J 38:301-306, 1997.
51. Iida H, Towatari M, Tanimoto M, Morishita Y, Kodera Y, Saito H. Overexpression of cyclin E in acute myelogenous leukemia. Blood 90:3707-3713, 1997.
52. Marone M, Scambia G, Giannitelli C, et al. Analysis of cyclin E and cdk2 in ovarian cancer: gene amplification and RNA expression. Int J Cancer 75:34-39, 1998.
53. Lukas J, Herzinger T, Hansen K, et al. Cyclin E-induced S phase without activation of the pRb/E2F pathway. Genes Dev 11:1479-1492, 1997.
54. Connell-Crowley L, Elledge SJ, Harper JW. G1 cyclin-dependent kinases are sufficient to initiate DNA synthesis in quiescent human fibroblasts. Curr Biol 8:65-68, 1998.
55. Won KA, Reed SI. Activation of cyclin E/cdk2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E. EMBO J 15:4182-4193, 1996.
56. Clurman BE, Sheaff RJ, Thress K, Groudine M, Roberts JM. Turnover of cyclin E by the ubiquitin-proteosome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev 10:1979-1990, 1996.